Previous Article | Next Article ![]()
Infection and Immunity, September 1998, p. 4130-4136, Vol. 66, No. 9
Department of Veterinary Microbiology and
Pathology, Washington State University, Pullman, Washington
99164-7040,1 and
Institute of Veterinary
Virology, University of Berne, CH-3012 Berne,
Switzerland2
Received 1 April 1998/Returned for modification 12 May
1998/Accepted 4 June 1998
Gamma interferon (IFN- Bovine babesiosis is an economically
important tick-borne disease of cattle that is caused by
intraerythrocytic apicomplexan parasites of the genus Babesia.
Babesia bovis-infected erythrocytes undergo sequestration by
attachment to capillary endothelium in a manner reminiscent of the most
severe form of human malaria, caused by Plasmodium
falciparum; this results in organ damage, cerebral dysfunction,
and pulmonary edema (58). It has been hypothesized that the
severe organ abnormalities that occur during acute B. bovis infection, similar to those observed during experimental malaria, are mediated in part by inflammatory cytokines, including gamma interferon (IFN- Although activation of macrophages could lead to immunopathological
consequences, macrophages are also believed to be important for
immunity to B. bovis and other intraerythrocytic
parasites via removal of parasitized erythrocytes by
phagocytosis and as antigen-presenting cells (APC) for
T-helper (Th) lymphocytes. Furthermore, macrophage secretory products
have been shown to inhibit the growth of P. falciparum
and B. bovis in vitro (24, 34). When
generated by chemical donors or activated macrophages in vitro, NO and
its reactive nitrogen intermediate derivatives were shown to inhibit
intracellular parasites including Leishmania major,
P. falciparum, and B. bovis (22,
23, 27, 40, 53, 54).
Studies in mice with B. microti, P. yoelii, P. vinckei, and P. chabaudi demonstrated that IFN- Experiments performed during the past decade showed that malarial
parasites and secreted toxins induced TNF- Several observations support the hypothesis that IFN- This study was undertaken to determine if bovine macrophages produce NO
when exposed to B. bovis in the presence or absence of
IFN- Parasite cultivation and antigen preparation.
The Mexico
strain of B. bovis was cultured in bovine erythrocytes
under microaerophilic conditions and crude antigens were prepared as
previously described (8). CM antigen, which contains pelleted parasite organelles and parasite membranes, was separated from
soluble, cytosolic high-speed supernatant (HSS) by lysing the
merozoites by two passages through a French pressure cell (SLM
Instruments, Inc., Urbana, Ill.) at 1,500 lb/in2 to obtain
a homogenate (H) and then by centrifugation at 145,000 × g for 1 h. Control CM antigen was prepared by hypotonic
lysis and centrifugation from uninfected bovine erythrocytes (RBC) from the same donor used to cultivate B. bovis. Protein
concentrations of parasite antigens were determined by the Bradford
assay (Bio-Rad, Hercules, Calif.) with a bovine serum albumin standard.
Working dilutions of B. bovis CM and recombinant bovine
IFN- Culture of bovine macrophages.
Macrophages were isolated
from PBMC by a modification of a previously described method
(38). Peripheral blood was collected from the jugular vein
into 60-ml syringes containing 2 ml of 0.5 M EDTA (Gibco BRL, Grand
Island, N.Y.) and centrifuged at 1,200 × g for 30 min.
Buffy coats were collected and diluted to 30 to 35 ml with 2 volumes of
Hanks balanced salt solution (Gibco BRL) containing 2 mM EDTA
(HBSS-EDTA), underlayered with 15 ml of Histopaque-1077 (Sigma, St.
Louis, Mo.) or Lymphoprep (Nycomed, Oslo, Norway), and centrifuged at
900 × g for 20 min. PBMC were then removed from the
interface between the plasma and Ficoll solution, pooled, diluted at
least 1:3 with HBSS-EDTA, and centrifuged at 500 × g
for 15 min. The pellets containing PBMC were then washed repeatedly at
250 × g until the supernatants were clear, resuspended
in complete RPMI 1640 medium, placed in 100-mm polystyrene petri dishes
(Becton Dickinson, Franklin Lakes, N.J.) at 1 × 107
to 2 × 107 PBMC/ml (10 ml/dish), and incubated for 1 to 3 h at 37°C in 5% CO2 in air. Nonadherent cells
were removed by washing the plates three times with prewarmed (37°C)
complete RPMI 1640 medium (8), which contained 10%
heat-inactivated fetal bovine serum (HyClone, Logan, Utah), and
adherent cells were cultured in 10 ml of complete RPMI at 37°C for an
additional 6 to 8 days to allow maturation into macrophages. After
approximately 1 week in culture, adherent macrophages were washed once
with prewarmed complete RPMI and once with Mg2+- and
Ca2+-containing HBSS, and removed by vortexing following
incubation at 37°C for 1 h in 0.5 mM EDTA in Mg2+-
and Ca2+-free HBSS.
Stimulation of macrophages in vitro.
Macrophages were
diluted to 106 cells/ml, and 100 µl/well was plated into
quadruplicate wells of 96-well, flat-bottom tissue culture plates
(Costar, Cambridge, Mass.) for NO2 NO2 Analysis of iNOS mRNA by reverse transcription-PCR.
Total
cellular RNA was isolated from macrophage cultures by using the TRIzol
reagent RNA isolation method as specified by the manufacturer (Gibco
BRL). RNA purity was assessed by the
A260/A280 ratio, and
integrity was verified by agarose gel electrophoresis. Total cellular
RNA (1 µg) was reverse transcribed in a 20-µl reaction mixture
containing 5 mM MgCl2, 1× PCR buffer, 1 mM deoxynucleoside triphosphates, 1 U of RNase inhibitor, 2.5 µM
oligo(dT)16, and 50 U of reverse transcriptase (RT)
(Perkin-Elmer, Branchburg, N.J.). The reactions, performed in a PCR
system 2400 thermal cycler (Perkin-Elmer), were performed under the
following incubation conditions: 25°C for 10 min, 42°C for 15 min,
and 99°C for 5 min; they were repeated at least once. Identical
reactions were performed for each sample without RT to verify the
absence of genomic DNA.
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Stimulation of Nitric Oxide Production in
Macrophages by Babesia bovis


![]()
ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
)-activated macrophages are believed to
play a key role in resistance to Babesia bovis through
parasite suppression by macrophage secretory products. However,
relatively little is known about interactions between this
intraerythrocytic parasite and the macrophages of its bovine host. In
this study, we examined the in vitro effect of intact and fractionated
B. bovis merozoites on bovine macrophage nitric oxide (NO)
production. In the presence of IFN-
, B. bovis merozoites
stimulated NO production, as indicated by the presence of increased
L-arginine-dependent nitrite
(NO2
) levels in culture supernatants of
macrophages isolated from several cattle. The merozoite crude membrane
(CM) fraction stimulated greater production of NO, in a dose-dependent
manner, than did the merozoite homogenate or the soluble, cytosolic
high-speed supernatant fraction. Stimulation of NO production by CM
was enhanced by as little as 1 U of IFN-
per ml of culture medium.
Upregulation of inducible NO synthase mRNA in bovine macrophages by
either B. bovis-parasitized erythrocytes and
IFN-
or CM was also observed. B. bovis-specific
T-helper lymphocyte culture supernatants, all of which contained
IFN-
, were also found to induce L-arginine-dependent NO2
production. Supernatants that induced the
highest levels of NO also contained biologically active TNF. These
results show that B. bovis merozoites and
antigen-stimulated B. bovis-immune T cells can induce
the production of NO, a molecule implicated in both protection
and pathologic changes associated with hemoprotozoan parasite
infections.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
) and tumor necrosis factor (TNF), and nitric oxide (NO) (58).
, TNF-
, and TNF-
are
important components of immunity to these parasites (3, 15, 32,
44, 47). IFN-
facilitates the phagocytosis of
P. falciparum-infected erythrocytes by human
macrophages (33, 35). In addition, parasite-specific, IFN-
-producing human CD4+ Th-cell clones inhibited the
growth of P. falciparum in the presence of adherent
peripheral blood mononuclear cells (PBMC) in vitro (18, 37).
The protective role of TNF-
appears to depend on the timing of its
appearance, which may partially explain the paradoxical roles of TNF in
protection and immunopathology. In resistant C57BL/6 mice,
TNF-
appeared early during P. chabaudi infection, whereas in susceptible A/J mice, high levels of TNF-
were
observed only late in infection, just preceding death (25).
in human and murine
macrophages and inducible NO synthase (iNOS) in murine macrophages.
Macrophages exposed in vitro to P. yoelii,
P. berghei, or P. falciparum produced
TNF-
, which was enhanced by IFN-
(4, 36, 50, 51).
Similarly, P. falciparum extract, in the presence of
IFN-
, stimulated murine macrophages to produce both TNF-
and NO
(31, 41). However, the interpretation of these results has
been questioned by the recent discovery that many continuously cultured
strains of P. falciparum are contaminated with
Mycoplasma species (56). Mycoplasma
organisms induce TNF-
and other inflammatory mediators in murine,
human, and bovine macrophages (28-30, 56), and experiments
with Mycoplasma-free P. falciparum are being
repeated to verify that the induction of inflammatory cytokines and NO was due to the parasite itself (43).
produced by
effector Th cells plays a key role in protection against babesiosis
(10). In cattle, IFN-
regulates B-cell synthesis of the
opsonizing immunoglobulin G2 subclass (17).
Parasite-specific Th-cell clones isolated from B. bovis-immune cattle produce IFN-
and TNF (11, 14).
Bovine macrophages have upregulated expression of iNOS when activated
by IFN-
in the presence of bacterial LPS (2) or TNF-
(20). Thus, the induction of macrophage iNOS by either
B. bovis extracts or antigen-activated T cells would be
indicative of macrophage activation and a potential babesiacidal effector mechanism. Conversely, overproduction of NO could also contribute to the pathologic changes associated with infection, including cerebral babesiosis.
. Potential Mycoplasma contamination of B. bovis cultures was ruled out by a PCR-based assay. We report,
for the first time, that bovine macrophages produce NO following in
vitro exposure to B. bovis merozoites or a
membrane-enriched fraction. The effect of different concentrations of
either IFN-
or B. bovis on NO production was also
examined. Furthermore, the functional relevance of B. bovis-specific Th cells that produce IFN-
and TNF was evaluated by the determining the ability of Th-cell supernatants to stimulate NO
production. Induction of iNOS was confirmed by demonstrating reduced
nitrite (NO2
) levels in the presence of
NG-monomethyl-L-arginine
(L-NMMA) and enhanced levels of iNOS steady-state mRNA in
macrophages cultured with B. bovis.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
in complete RPMI tested negative for endotoxin by the Endotect
Limlulus amebocyte lysate assay (ICN, Aurora, Ohio), which
has a sensitivity of 0.06 to 0.1 ng/ml. In addition, more than 25 samples of B. bovis HSS and CM fractions collected over
a period of 4 years and 4 preparations of purified B. bovis DNA were shown to be negative for Mycoplasma by
PCR with the Mycoplasma PCR primer set (Stratagene, La
Jolla, Calif.) as specified by the manufacturer.
assays.
Alternatively, cells (3 × 106 cells) were plated into
six-well plates for RNA isolation. The cells were left to adhere
overnight at 37°C in 5% CO2 in air. The culture medium
was then removed and replaced with complete RPMI alone or containing
the indicated amounts of antigen prepared from B. bovis-infected or uninfected RBC, which included B. bovis H, CM, or HSS and RBC CM. As a positive control for
induction of iNOS, macrophages were also cultured with
lipopolysaccharide (LPS) from Escherichia coli O55:B5
(Sigma). Cultures were performed with or without recombinant bovine
IFN-
(Ciba-Geigy; kindly provided by Lorne Babiuk, VIDO, Saskatoon,
Canada) and/or 250 µM L-NMMA (CalBiochem, San Diego,
Calif.). Macrophages were also incubated with B. bovis-infected RBC which contained approximately 4 or 10%
parasitized RBC (PPE) at a 2.5% final packed-cell volume (PCV). As a
negative control, uninfected RBC from the same donor cow used for
parasite culture were also added at the same final PCV. Supernatants
harvested from Th-cell lines specific for B. bovis were
also added to macrophages at a final dilution of 75% (vol/vol).
detection by the Griess
reaction.
Macrophage culture supernatants were transferred (50 µl/well) to new 96-well, flat-bottom plates, 50 µl of 1% (wt/vol)
sulfanilamide (Sigma) in 2.5% H3PO4 and then
50 µl of 0.1% (wt/vol) naphthylethylenediamine dihydrochloride
(Sigma) in 2.5% H3PO4 were added to the
supernatants, and the absorbance at 540 nm
(A540) was compared to a NaNO2
standard curve. Preliminary studies demonstrated that
NO2
measurement by the Griess reaction was
optimal after the macrophages were cultured with the appropriate
stimulus for 96 h. The results are presented as the mean
micromolar concentration of NO2
in
quadruplicate cultures ± 1 standard deviation (SD). Student's one-tailed t test was used to determine statistically
significant differences in NO2
production.
-actin sense primer
(5'-ACCAACTGGGACGACATGGAG-3') and antisense primer
(5'-GCATTTGCGGTGGACAATGGA-3'), which amplify an 890-bp
product (16). The actin primer sequences were kindly provided by Gary Splitter, Department of Animal Health and Biomedical Sciences, University of Wisconsin, Madison, Wisconsin. PCRs for bovine
iNOS were performed with a 1:50 dilution of the DNA product (5 ng of
RNA equivalent). Equivalence of the template was assessed by parallel
amplification of bovine
-actin. PCRs for bovine
-actin were
performed with a 1:5,000 dilution of the DNA product (0.05 ng of RNA
equivalent). Other components of the 50-µl reaction mixture included
2.5 mM MgCl2, 1× PCR buffer, 0.4 mM deoxynucleoside triphosphates, and 1 U of AmpliTaq Gold (Perkin-Elmer). Activation of
AmpliTaq Gold required a 10-min preamplification incubation at 94°C,
after which cDNA was amplified for 35 cycles consisting of 94°C for 1 min, 60°C for 1 min, and 72°C for 2 min. The final extension was
allowed to continue for 10 min. Each PCR product (25 µl) was
electrophoresed on a 1% agarose gel containing 0.5 µg of ethidium
bromide per ml. PCR products were visualized under UV light and
analyzed with the IS1000 gel imaging system (Alpha Innotech, San
Leandro, Calif.). Negative controls included simultaneous amplification
of reaction mixtures without RT or without template.
T-cell lines and proliferation. Cell lines were established by culturing 4 × 106 PBMC in 1.5 ml of complete RPMI 1640 medium with B. bovis (Mexico) CM antigen (25 µg/ml) per well in 24-well plates (Costar) as described previously (7). T lymphocytes were subcultured under the same conditions weekly for up to 10 weeks at a density of 5 × 105 cells/well with CM antigen and 2 × 106 irradiated (3,000 rads) autologous PBMC as a source of APC. As previously shown (7), the B. bovis-specific T-cell lines used in the studies reported here contained predominantly CD4+ T cells (48) as shown by flow cytometry analysis. Proliferation assays were performed essentially as described previously (7) with 3 × 104 T cells, 2 × 105 APC, and 1 to 25 µg of antigen per ml; the antigen consisted of either B. bovis CM or control uninfected RBC membranes prepared from the same source of RBC used for in vitro cultivation of B. bovis. The assays were conducted in triplicate, and the mixtures were radiolabeled with 0.25 µCi of [3H]thymidine (Dupont New England Nuclear, Boston, Mass.) during the final 6 h of culture, harvested, and counted in a liquid scintillation counter. The results are presented as the mean cpm ± 1 SD of triplicate cultures.
IFN-
ELISA and TNF bioassays.
Supernatants were collected
from B. bovis-specific CD4+ T-cell lines
derived from animals C97, G3, and G6 in culture for 6 weeks (animal G3)
or 10 weeks (animals C97 and G6) and after 7 days of stimulation with
B. bovis antigen and APC. Supernatants were centrifuged
to pellet cellular debris and assayed for IFN-
with a commercial
enzyme-linked immunosorbent assay (ELISA) kit (IDEXX Laboratories,
Westbrook, Maine) as specified by the manufacturer. IFN-
protein was
estimated from a standard curve derived with a dilution series of a
cloned Th-cell culture supernatant that was shown to contain 400 U of
IFN-
per ml by the vesicular stomatitis virus cytopathic effect
reduction assay with Madin-Darby bovine kidney cells (13).
Recombinant bovine IFN-
similarly assayed for vesicular stomatitis
virus neutralization contained approximately 0.6 U of biological
activity per ng of protein (6).
as a standard has been described
previously (11). Cytopathicity was determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) dye
reduction assay. TNF titers in the supernatants were compared with a
standard murine recombinant TNF-
(Genzyme, Cambridge, Mass.) that
had a reported activity of 2 × 106 U/ml and in our
assay had a titer of 4.5 × 105 U/ml.
| |
RESULTS |
|---|
|
|
|---|
Mycoplasma detection assay. Aliquots of more than 25 B. bovis CM or HSS preparations and 4 samples of purified B. bovis DNA were assayed for Mycoplasma contamination by PCR with primers that amplify DNA from several different species of Mycoplasma. All the samples were negative, demonstrating that the cultured B. bovis parasites used in these experiments were free of Mycoplasma (data not shown).
L-Arginine-dependent production of
NO2
by bovine macrophages.
To determine
whether B. bovis could stimulate NO production by
bovine macrophages, peripheral blood monocyte-derived macrophages were
isolated from four cattle and stimulated for 96 h with either LPS
or B. bovis antigens with or without bovine IFN-
. NO
production was determined by measurement of
NO2
, a stable derivative of NO, levels in
culture supernatants by the Griess assay. Although the level of
NO2
produced varied among the animals,
macrophages isolated from all cattle and stimulated with IFN-
(500 U/ml) and either LPS (2 µg/ml) or B. bovis CM antigen
(100 µg of protein/ml) generated significantly greater levels of
NO2
than did macrophages cultured with either
IFN-
or CM alone (Table 1). The
NO2
concentration in supernatants from
macrophages cultured with IFN-
plus H, HSS, CM, or LPS were all
found to be significantly greater (P < 0.05) than that
in supernatants from macrophages cultured with medium, RBC, IFN-
, or
RBC plus IFN-
(Fig. 1). In this
experiment, NO2
production by macrophages
incubated with CM and IFN-
was comparable to that produced by
macrophages stimulated by LPS and IFN-
and was significantly greater
(P < 0.001) than that produced by macrophages stimulated with IFN-
and either H or HSS. Culturing macrophages with
or without LPS, RBC, B. bovis, or IFN-
alone or with
RBC plus IFN-
failed to induce NO2
production. Addition of the L-arginine analog
L-NMMA (250 µM) abrogated NO2
generation by macrophages stimulated with IFN-
in combination with
LPS or the B. bovis crude antigen preparations.
|
|
NO production by bovine macrophages stimulated with B. bovis and IFN-
is dose dependent.
To determine if the
production of NO was dependent on the concentration of either
B. bovis CM or IFN-
, bovine macrophages were
stimulated with 6.25 to 200 µg of CM per ml in the presence of 0, 100, 500, or 1,000 U of IFN-
per ml (Fig.
2A) or serial dilutions of IFN-
(ranging from 0 to 1,000 U/ml) in the presence of 100 µg of
B. bovis CM per ml (Fig. 2B and C).
NO2
production increased proportionally with
increasing concentrations of CM when combined with a single
concentration of IFN-
(Fig. 2A). However, there was no apparent
difference in NO2
production by macrophages
exposed to one concentration of CM and 100, 500, or 1,000 U of IFN-
per ml. In a separate experiment, similar levels of
NO2
were induced by CM and 8 to 1,000 U of
IFN-
per ml whereas CM alone or CM plus IFN-
plus
L-NMMA failed to induce NO2
(Fig.
2B). To further define the minimal amount of IFN-
required for
costimulation with CM, IFN-
was added from 0.03 to 8.0 U/ml and a
dose-dependent effect was achieved (Fig. 2C). These data suggested that
very little, and perhaps a biologically relevant amount of, IFN-
is
required to enhance NO production in B. bovis-stimulated macrophages.
|
B. bovis induces the expression of iNOS mRNA.
To confirm the enhanced production of NO in macrophages stimulated with
B. bovis CM and IFN-
, steady-state mRNA for iNOS was
examined in cells cultured with B. bovis CM,
B. bovis-infected RBC, or uninfected RBC. Reverse
transcription-PCR analysis revealed that iNOS mRNA expression was
detected in macrophages cultured for 6 h with B. bovis CM, CM plus IFN-
, or LPS plus IFN-
but was not
detected in cells cultured with medium or IFN-
alone (Fig.
3A). iNOS mRNA levels were higher in
macrophages cultured with B. bovis CM and IFN-
for 6 or 24 h than in macrophages cultured with IFN-
alone (Fig. 3A
and B). Furthermore, the iNOS mRNA levels were higher in macrophages
cultured for 24 h with CM alone than in macrophages cultured with
medium (Fig. 3B). Similar results were obtained with macrophages
cultured with B. bovis CM with or without IFN-
for 2 and 48 h (data not shown). Although CM alone did not induce
NO2
production, there was no detectable
difference in the level of iNOS mRNA between cells cultured with CM
alone and cells cultured with CM plus IFN-
as determined by
densitometry image analysis and comparison with actin data (data not
shown). When macrophages were examined after 24 h of culture with
B. bovis CM, the effect of IFN-
on cells stimulated
with either LPS or CM was also not apparent (Fig. 3B). To confirm the
ability of babesial parasites to induce iNOS, freshly harvested
parasitized RBC or control, cultured uninfected RBC from the same donor
animal were used as the stimulus in 6- or 24-h macrophage cultures
(Fig. 3C and D). Macrophages cultured for 6 h had low levels of
iNOS steady-state mRNA in the presence of medium or RBC and IFN-
(Fig. 3C). Compared with medium, culture with infected RBC alone
resulted in an approximately eightfold increase in the level of
steady-state iNOS mRNA, and compared with uninfected RBC plus IFN-
,
culture with infected RBC plus IFN-
resulted in an approximate
fourfold increase in the level of steady-state iNOS mRNA (Fig. 3C). In
a separate experiment, culture of macrophages for 24 h revealed
increased iNOS transcript levels only in the presence of infected RBC
and IFN-
, and uninfected RBC again did not stimulate iNOS. The
differences in baseline levels of iNOS expressed by macrophages
cultured for either 6 or 24 h in the absence of Babesia
are probably due to differing activation states of the cultures, which
were obtained from different donor animals (G4, G5, and G6) at
different times.
|
Macrophage stimulation by Th-cell culture supernatants.
B. bovis-specific CD4+ Th-cell lines
produce both IFN-
and TNF-
(11). To determine whether
the secreted products of antigen-stimulated B. bovis-specific CD4+ T cells could activate macrophages
to produce NO, macrophages were cultured for 96 h with
supernatants harvested from T-cell lines stimulated with B. bovis CM and APC. The cell lines, in culture for 6 weeks (G3) or
10 weeks (C97 and G6), responded specifically by proliferation in
response to B. bovis CM antigen compared with control
uninfected RBC antigen (Table 2).
NO2
production by macrophages cultured with
supernatants from all three Th-cell lines was significantly greater
(P < 0.05, by the Student t test) than that
induced by either medium or IFN-
(1,000 U/ml) alone (Fig.
4). Addition of L-NMMA
significantly inhibited NO2
production
(P < 0.05), demonstrating that the
NO2
levels were generated by macrophages and
were not due to NO2
present in the T-cell
supernatants themselves. L-NMMA had no effect on
NO2
production by macrophages cultured in
medium or IFN-
alone. Supernatants of B. bovis-specific Th-cell lines from animals C97, G3, and G6
contained 151, 17, and 154 U of IFN-
per ml and 9, <1, and 11 U of
TNF per ml, respectively (Table 2). Interestingly, supernatants from
cell lines that induced the highest levels of NO (C97 and G6) also had
the highest levels of IFN-
and TNF.
|
|
| |
DISCUSSION |
|---|
|
|
|---|
This report is the first to demonstrate the induction of iNOS and
production of NO in bovine macrophages by the protozoal parasite
B. bovis. Mycoplasma contamination of our cultures was ruled out (56). While NO2
levels
were significantly increased in culture supernatants of CM- plus
IFN-
-stimulated macrophages isolated from each animal tested, there
was evidence of donor-dependent variation in NO production (Table 1),
as described previously (1). Variation from experiment to
experiment in the levels of NO2
produced
after stimulation with either CM or LPS was also observed and probably
reflects the different activation states of these primary cell
cultures. Bovine iNOS activity was detected at some level when
macrophages were exposed to IFN-
in combination with each
B. bovis merozoite preparation tested. However, the
highest levels of NO2
were present in
supernatants of macrophages cultured with CM and IFN-
, indicating
that the stimulatory B. bovis component may be
insoluble and/or closely associated with merozoite membranes, organelles, or vesicles that are not disrupted by lysis in the French
press. The source of NO2
detected by the
Griess reaction was confirmed to be L-arginine through
inhibition of NO2
generation by the
L-arginine analog L-NMMA. The upregulation of
iNOS by B. bovis CM and infected RBC was also confirmed
at the transcriptional level.
Activation of bovine macrophages by IFN-
produced by
parasite-specific Th1 and Th0 lymphocytes (11) is
hypothesized to be important for B. bovis parasite
clearance after challenge infection of immune hosts (9, 12),
but the mechanism of parasite inhibition by activated macrophages has
not been determined. Phagocytosis of parasitized RBC is one way in
which activated macrophages may remove parasites from the host
(26), and preliminary results indicated that macrophages
activated by adherence to plastic alone inhibited parasite replication
(45). Macrophage secretory products were also reportedly
toxic for P. falciparum and B. bovis
parasites in vitro (24, 34). P. falciparum
was shown to induce TNF-
in both human and murine macrophages
(4, 5, 36, 39, 50-52) and NO production in murine
macrophages in vitro (41). However, recent evidence that
P. falciparum cultures are commonly contaminated with
Mycoplasma (56), a prokaryote known to induce TNF-
and other inflammatory molecules in macrophages (28-30,
56), indicates that the interpretation of these earlier studies
will require further experimentation (43). The secretory
products that directly inhibit B. bovis in vitro do not
include TNF-
itself (49), but NO and its reactive
nitrogen intermediate derivatives were inhibitory for both
B. bovis and P. falciparum in vitro
(24, 27, 40, 53). Thus, the present study provides a link
between the observed effector function of NO and its induction by
B. bovis parasites and specific Th-cell products.
The induction of iNOS by CM occurred in the absence of IFN-
, and
addition of exogenous IFN-
did not appear to increase the level
of mRNA, whereas NO2
production was
significantly enhanced when macrophages were cocultured with CM and
IFN-
. These differences probably reflect the different assay
sensitivities, and RT-PCR is useful only for demonstrating relative
differences in mRNA levels. Bovine macrophages stimulated with viruses
or gram-positive bacteria also had upregulated levels of iNOS or NO in
the absence of IFN-
(1, 2). Of interest was the
relatively low, and perhaps physiologically relevant, level of IFN-
(1 U/ml) required to enhance NO generation in the presence of
B. bovis CM. The supernatants obtained from
antigen-stimulated Th-cell lines all contained titers of IFN-
sufficient to induce NO production by macrophages. These supernatants,
which were diluted before being added to the macrophages, could have
contained no more than 20 µg of CM antigen per ml, a concentration
that was suboptimal for stimulating NO when combined with IFN-
(Fig.
2A). Furthermore, recombinant bovine IFN-
alone did not induce NO production by macrophages in this or other studies (2).
Together, these data suggest that other products in addition to
residual antigen, such as TNF-
and/or TNF-
present in the Th-cell
supernatants, may be mediating macrophage costimulation. In support of
this possibility, the presence of biologically active TNF in these supernatants correlated with NO production. Furthermore, others have
demonstrated that recombinant TNF-
plus IFN-
can upregulate both
iNOS and NO2
in bovine (20) and
murine (39) macrophages. Thus, our results are consistent
with the possibilities that IFN-
and TNF produced by
parasite-specific Th cells can stimulate NO production in the presence of small amounts of antigen and that B. bovis merozoite antigen, either alone or with IFN-
, can
induce iNOS indirectly through stimulation of macrophage TNF-
.
NO is a molecule with a diverse array of biological functions,
including immunoregulatory ones (57). Recently, endogenous expression of NO was shown to be required for transcriptional upregulation of the IL-12 p40 subunit, but not the p35 subunit, in
murine macrophages activated by IFN-
(42). Since IL-12 is one of the key cytokines required for enhanced IFN-
production by NK
cells and T cells and for priming of a type 1 Th-cell response (55), activation of macrophages by protozoal parasites and
their products may contribute to the induction of a type 1 immune
response, provided that IL-12 p35 is sufficiently expressed to
form the biologically active heterodimer. This type of immune
response could then lead to either enhanced parasite clearance or
pathologic consequences, the latter of which were found in a murine
malaria model to be dependent on TNF-
and IFN-
(21).
Alternatively, selective production of IL-12 p40 could result in the
formation of p40 homodimers, which can theoretically antagonize
functional IL-12 heterodimeric activity and interfere with induction
and activation of type 1 immune responses (19). Preliminary
results in our laboratory showed an upregulation of TNF-
and both
IL-12 p35 and p40 subunits in macrophages cultured with B. bovis CM and IFN-
(46). Thus, NO production by
bovine monocyte-derived macrophages following exposure to B. bovis is indicative of an activation state that reflects a
complex host-parasite interaction.
While NO production has been induced in murine macrophages by an
extract of the human parasite P. falciparum
(41), the present study is, to our knowledge, the first to
demonstrate induction of iNOS by an apicomplexan parasite in
monocyte-derived macrophages from a nonrodent species. Studies
to investigate the potential link between upregulation of
macrophage iNOS and cytokines IL-12 and TNF-
following exposure to
B. bovis, to elucidate the roles of NO and IL-12 in the
initiation of the immune response to B. bovis, and to
define the mechanisms by which activated macrophages inhibit
B. bovis replication are under way. Identification of the parasite products that induce the production of NO and inflammatory cytokines and that are enriched in the CM fraction may also prove useful in the design of vaccines for B. bovis and
related hemoparasites.
| |
ACKNOWLEDGMENTS |
|---|
We thank Sue Ellen Chantler, Kim Kegerreis, Debby Alperin, and Daming Zhu for technical assistance and Tien-min Chou and Bill Davis for their advice during the course of this work.
This research was supported by National Institutes of Health NIAID grant R01-AI30136.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Veterinary Microbiology and Pathology, Washington State University, Pullman, WA 99164-7040. Phone: (509) 335-6067. Fax: (509) 335-8529. E-mail: wbrown{at}vetmed.wsu.edu.
Present address: Department of Veterinary Preventive Medicine, Ohio
State University, Columbus, OH 43210-1092.
Present address: Institute for Clinical and Molecular Biology,
D-81377 Munich, Germany.
Editor: J. M. Mansfield
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Adler, H., B. Frech, P. Meier, T. W. Jungi, and E. Peterhans. 1994. Noncytopathic strains of bovine viral diarrhea virus prime bovine bone marrow-derived macrophages for enhanced generation of nitric oxide. Biochem. Biophys. Res. Commun. 202:1562-1568[Medline]. |
| 2. | Adler, H., B. Frech, M. Thony, H. Pfister, E. Peterhans, and T. W. Jungi. 1995. Inducible nitric oxide synthase in cattle. Differential cytokine regulation of nitric oxide synthase in bovine and murine macrophages. J. Immunol. 154:4710-4718[Abstract]. |
| 3. | Amante, F. H., and M. F. Good. 1997. Prolonged Th1-like response generated by a Plasmodium yoelii-specific T cell clone allows complete clearance of infection in reconstituted mice. Parasite Immunol. 19:111-126[Medline]. |
| 4. | Bate, C. A. W., J. Taverne, and J. H. L. Playfair. 1988. Malarial parasites induce TNF production by macrophages. Immunology 64:227-231[Medline]. |
| 5. | Bate, C. A. W., J. Taverne, and J. H. L. Playfair. 1989. Soluble malarial antigens are toxic and induce the production of tumor necrosis factor in vivo. Immunology 66:600-605[Medline]. |
| 6. | Beyer, J. C., R. W. Stich, W. C. Brown, and W. P. Cheevers. 1998. Cloning and expression of caprine interferon-gamma. Gene 210:103-108[Medline]. |
| 7. | Brown, W. C., and K. S. Logan. 1992. Babesia bovis: bovine helper T cell lines reactive with soluble and membrane antigens of merozoites. Exp. Parasitol. 74:188-199[Medline]. |
| 8. |
Brown, W. C.,
K. S. Logan,
G. G. Wagner, and C. L. Tetzlaff.
1991.
Cell-mediated immune responses to Babesia bovis merozoite antigens in cattle following infection with tick-derived or cultured parasites.
Infect. Immun.
59:2418-2426 |
| 9. | Brown, W. C., and A. C. Rice-Ficht. 1994. Use of helper T cells to identify potential vaccine antigens of Babesia bovis. Parasitol. Today 10:145-149. [Medline] |
| 10. |
Brown, W. C.,
V. M. Woods,
C. G. Chitko-McKown,
S. M. Hash, and A. C. Rice-Ficht.
1994.
Interleukin-10 is expressed by bovine type 1 helper, type 2 helper, and unrestricted parasite-specific T-cell clones and inhibits proliferation of all three subsets in an accessory-cell-dependent manner.
Infect. Immun.
62:4697-4708 |
| 11. |
Brown, W. C.,
V. M. Woods,
D. A. E. Dobbelaere, and K. S. Logan.
1993.
Heterogeneity in cytokine profiles of Babesia bovis-specific bovine CD4+ T-cell clones activated in vitro.
Infect. Immun.
61:3273-3281 |
| 12. | Brown, W. C., S. Zhao, K. S. Logan, D. J. Grab, and A. C. Rice-Ficht. 1995. Identification of candidate vaccine antigens of bovine hemoparasites Theileria parva and Babesia bovis by use of helper T cell clones. Vet. Parasitol. 57:189-203[Medline]. |
| 13. |
Brown, W. C.,
S. Zhao,
A. C. Rice-Ficht,
K. S. Logan, and V. M. Woods.
1992.
Bovine helper T cell clones recognize five distinct epitopes on Babesia bovis merozoite antigens.
Infect. Immun.
60:4364-4372 |
| 14. | Brown, W. C., and D. M. Estes. 1997. Type I and type II responses in cattle and their regulation, p. 15-33. In V. E. C. J. Schijns, and M. Horzinek (ed.), Cytokines in veterinary medicine. CAB International, Wallingford, United Kingdom. |
| 15. | Clark, I. A., N. H. Hunt, G. A. Butcher, and W. B. Cowden. 1987. Inhibition of murine malaria (Plasmodium chabaudi) in vivo by recombinant interferon-gamma or tumor necrosis factor, and its enhancement by butylated hydroxyanisole. J. Immunol. 139:3493-3496[Abstract]. |
| 16. |
Degen, J. L.,
M. G. Neubauer,
S. J. Degen,
C. E. Seyfried, and D. R. Morris.
1983.
Regulation of protein synthesis in mitogen-activated bovine lymphocytes. Analysis of actin-specific and total mRNA accumulation and utilization.
J. Biol. Chem.
258:12153-12162 |
| 17. | Estes, D. M., N. M. Closser, and G. K. Allen. 1994. IFN-gamma stimulates IgG2 production from bovine B cells costimulated with anti-µ and mitogen. Cell. Immunol. 154:287-295[Medline]. |
| 18. | Fell, A. H., J. Currier, and M. F. Good. 1994. Inhibition of Plasmodium falciparum growth in vitro by CD4+ and CD8+ T cells from non-exposed donors. Parasite Immunol. 16:579-586[Medline]. |
| 19. | Gillessen, S., D. Carvajal, P. Ling, F. J. Podlaski, D. L. Stremlo, P. C. Familletti, U. Gubler, D. H. Presky, A. S. Stern, and M. K. Gately. 1995. Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist. Eur. J. Immunol. 25:200-206[Medline]. |
| 20. | Goff, W. L., W. C. Johnson, C. R. Wyatt, and C. W. Cluff. 1996. Assessment of bovine mononuclear phagocytes and neutrophils for induced L-arginine-dependent nitric oxide production. Vet. Immunol. Immunopathol. 55:45-62[Medline]. |
| 21. | Grau, G. E., P.-F. Piguet, P. Vassalli, and P.-H. Lambert. 1989. Tumor-necrosis factor and other cytokines in cerebral malaria: experimental and clinical data. Immunol. Rev. 112:49-70[Medline]. |
| 22. | Green, S. J., S. Mellouk, S. L. Hoffman, M. S. Meltzer, and C. A. Nacy. 1990. Cellular mechanisms of nonspecific immunity to intracellular infection: cytokine-induced synthesis of toxic nitrogen oxides from L-arginine by macrophages and hepatocytes. Immunol. Lett. 25:15-19[Medline]. |
| 23. | Green, S. J., M. S. Meltzer, J. B. Hibbs, Jr., and C. A. Nacy. 1990. Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. J. Immunol. 144:278-283[Abstract]. |
| 24. | Gyan, B., M. Troye-Blomberg, P. Perlmann, and A. Bjorkman. 1994. Human monocytes cultured with and without interferon-gamma inhibit Plasmodium falciparum parasite growth in vitro via secretion of reactive nitrogen intermediates. Parasite Immunol. 16:371-375[Medline]. |
| 25. | Jacobs, P., D. Radzioch, and M. M. Stevenson. 1996. A Th1-associated increase in tumor necrosis factor alpha expression in the spleen correlates with resistance to blood-stage malaria in mice. Infect. Immun. 64:535-541[Abstract]. |
| 26. | Jacobson, R. H., F. Parrodi, I. G. Wright, C. J. Fitzgerald, and C. Dobson. 1993. Babesia bovis: in vitro phagocytosis promoted by immune serum and by antibodies produced against protective antigens. Parasitol. Res. 79:221-226[Medline]. |
| 27. | Johnson, W. C., C. W. Cluff, W. L. Goff, and C. R. Wyatt. 1996. Reactive oxygen and nitrogen intermediates and products from polyamine degradation are babesiacidal in vitro. Ann. N. Y. Acad. Sci. 791:136-147[Abstract]. |
| 28. | Jungi, T. W., M. Krampe, M. Sileghem, C. Griot, and J. Nicolet. 1996. Differential and strain-specific triggering of bovine alveolar macrophage effector functions by mycoplasmas. Microb. Pathog. 21:487-98[Medline]. |
| 29. | Kita, M., Y. Ohmoto, Y. Hirai, N. Yamaguchi, and J. Imanishi. 1992. Induction of cytokines in human peripheral blood mononuclear cells by mycoplasmas. Microbiol. Immunol. 36:507-516[Medline]. |
| 30. | Kostyal, D. A., G. H. Butler, and D. H. Beezhold. 1995. Mycoplasma hyorhinis molecules that induce tumor necrosis factor alpha secretion by human monocytes. Infect. Immun. 63:3858-3863[Abstract]. |
| 31. | Kremsner, P. G., A. Nussler, S. Neifer, M. F. Chaves, U. Bienzle, G. Senaldi, and G. E. Grau. 1993. Malaria antigen and cytokine-induced production of reactive nitrogen intermediates by murine macrophages: no relevance to the development of experimental cerebral malaria. Immunology 78:286-290[Medline]. |
| 32. | Kumar, S., and L. H. Miller. 1990. Cellular mechanisms in immunity to blood stage infection. Immunol. Lett. 25:109-114[Medline]. |
| 33. | Kumaratilake, L. M., and A. Ferrante. 1992. IL-4 inhibits macrophage-mediated killing of Plasmodium falciparum in vitro. A possible parasite-immune evasion mechanism. J. Immunol. 149:194-199[Abstract]. |
| 34. |
Montealegre, F.,
M. G. Levy,
M. Ristic, and M. A. James.
1985.
Growth inhibition of Babesia bovis in culture by secretions from bovine mononuclear phagocytes.
Infect. Immun.
50:523-526 |
| 35. | Ockenhouse, C. F., S. Schulman, and H. L. Shear. 1984. Induction of crisis forms in the human malaria parasite Plasmodium falciparum by gamma-interferon-activated, monocyte-derived macrophages. J. Immunol. 133:1601-1608[Abstract]. |
| 36. |
Picot, S.,
F. Peyron,
J.-P. Vuillez,
G. Barbe,
K. Marsh, and P. Ambroise-Thomas.
1990.
Tumor necrosis factor production by human macrophages stimulated in vitro by Plasmodium falciparum.
Infect. Immun.
58:214-216 |
| 37. | Quakyi, I. A., J. Currier, A. Fell, D. W. Taylor, T. Roberts, R. A. Houghten, R. D. England, J. A. Berzofsky, L. H. Miller, and M. F. Good. 1994. Analysis of human T cell clones specific for conserved peptide sequences within malaria proteins. Paucity of clones responsive to intact parasites. J. Immunol. 153:2082-2092[Abstract]. |
| 38. | Rafie-Kolpin, M., R. C. Essenberg, and J. H. Wyckoff, III. 1996. Identification and comparison of macrophage-induced proteins and proteins induced under various stress conditions in Brucella abortus. Infect. Immun. 64:5274-5283[Abstract]. |
| 39. |
Rockett, K. A.,
M. M. Awburn,
B. B. Aggarwal,
W. B. Cowden, and I. A. Clark.
1992.
In vivo induction of nitrite and nitrate by tumor necrosis factor, lymphotoxin, and interleukin-1: possible roles in malaria.
Infect. Immun.
60:3725-3730 |
| 40. |
Rockett, K. A.,
M. M. Awburn,
W. B. Cowden, and I. A. Clark.
1991.
Killing of Plasmodium falciparum in vitro by nitric oxide derivatives.
Infect. Immun.
59:3280-3283 |
| 41. | Rockett, K. A., D. Kwiatkowski, C. A. W. Bate, M. M. Awburn, E. J. Rockett, and I. A. Clark. 1996. In vitro induction of nitric oxide by an extract of Plasmodium falciparum. J. Infect. 32:187-196[Medline]. |
| 42. | Rothe, H., B. Hartmann, P. Geerlings, and H. Kolb. 1996. Interleukin-12 gene-expression of macrophages is regulated by nitric oxide. Biochem. Biophys. Res. Commun. 224:159-163[Medline]. |
| 43. | Row, J. A., I. Scragg, D. Kwiatkowski, D. J. Ferguson, D. J. Carucci, and C. I. Newbold. 1997. Mycoplasma contamination of Plasmodium falciparum cultures: detection, eradication, and implications, abstr. P24a. In British Society for Parasitology Ninth Malaria Meeting. |
| 44. | Ruebush, M. J., and W. L. Hanson. 1980. Transfer of immunity to Babesia microti of human origin using T lymphocytes in mice. Cell. Immunol. 52:255-265[Medline]. |
| 45. | Shoda, L. K. M., R. W. Stich, and W. C. Brown. Unpublished observations. |
| 46. |
Shoda, L. K. M.,
R. W. Stich,
M. Dreewes, and W. C. Brown.
1998.
Induction of IL-12 p35, IL-12 p40, TNF- , and iNOS in bovine macrophages by Babesia bovis or fractionated antigen, abstr. 61.
In
Second Woods Hole Immunoparasitology Meeting.
|
| 47. | Stevenson, M. M., M. F. Tam, and M. Nowotarski. 1990. Role of interferon-gamma and tumor necrosis factor in host resistance to Plasmodium chabaudi AS. Immunol. Lett. 25:115-121[Medline]. |
| 48. | Stich, R. W., A. C. Rice-Ficht, W. Tuo and W. C. Brown. Babesia bovis: common protein fractions recognized by oligoclonal B. bovis-specific CD4+ T cell lines from genetically diverse cattle. Submitted for publication. |
| 49. | Tambrallo, L. J., G. M. Buening, and R. M. McLaughlin. 1992. The effect of neutrophils, tumor necrosis factor, and granulocyte macrophage/colony stimulating factor on Babesia bovis and Babesia bigemina in culture. Vet. Parasitol. 43:177-188[Medline]. |
| 50. |
Taverne, J.,
C. A. W. Bate,
D. Kwiatkowski,
P. H. Jakobsen, and J. H. L. Playfair.
1990.
Two soluble antigens of Plasmodium falciparum induce tumor necrosis factor release from macrophages.
Infect. Immun.
58:2923-2928 |
| 51. | Taverne, J., C. A. W. Bate, and J. H. L. Playfair. 1990. Malaria exoantigens induce TNF, are toxic and are blocked by T-independent antibody. Immunol. Lett. 25:207-212[Medline]. |
| 52. | Taverne, J., C. A. W. Bate, D. A. Sarkar, A. Meager, G. A. Rook, and J. H. L. Playfair. 1990. Human and murine macrophages produce TNF in response to soluble antigens of Plasmodium falciparum. Parasite Immunol. 12:33-43[Medline]. |
| 53. | Taylor-Robinson, A. W. 1997. Antimalarial activity of nitric oxide: cytostasis and cytotoxicity towards Plasmodium falciparum. Biochem. Soc. Trans. 25:262S[Medline]. |
| 54. |
Taylor-Robinson, A. W.,
R. S. Phillips,
A. Severn,
S. Moncada, and F. Y. Liew.
1993.
The role of TH1 and TH2 cells in a rodent malaria infection.
Science
260:1931-1934 |
| 55. | Trinchieri, G. 1995. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:251-276[Medline]. |
| 56. |
Turrini, F.,
G. Giribaldi,
E. Valente, and P. Arese.
1997.
Mycoplasma contamination of Plasmodium cultures a case study of parasite parasitism.
Parasitol. Today
13:367-368.
[Medline] |
| 57. | Wei, X. Q., I. G. Charles, A. Smith, J. Ure, G. J. Feng, F. P. Huang, D. Xu, W. Muller, S. Moncada, and F. Y. Liew. 1995. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375:408-411[Medline]. |
| 58. | Wright, I. G., B. V. Goodger, and I. A. Clark. 1988. Immunopathophysiology of Babesia bovis and Plasmodium falciparum infections. Parasitol. Today 4:214-218. |
This article has been cited by other articles: